Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans
出版年份 2022 全文链接
标题
Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans
作者
关键词
-
出版物
VACCINE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-08-01
DOI
10.1016/j.vaccine.2022.07.035
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
- (2022) Miwako Kobayashi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age
- (2021) Nicola P. Klein et al. VACCINE
- Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
- (2020) Donald Hurley et al. CLINICAL INFECTIOUS DISEASES
- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
- (2019) Almea Matanock et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Validation of discharge diagnosis codes to identify serious infections among middle age and older adults
- (2018) Andrew D Wiese et al. BMJ Open
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
- (2018) James T. Peterson et al. Human Vaccines & Immunotherapeutics
- Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review
- (2016) Cornelius Remschmidt et al. BMC INFECTIOUS DISEASES
- Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
- (2016) Naomi J. Gadsby et al. CLINICAL INFECTIOUS DISEASES
- Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
- (2015) Seema Jain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age
- (2014) Richard N. Greenberg et al. VACCINE
- Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study
- (2013) Daniel M. Musher et al. JOURNAL OF INFECTION
- Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia
- (2013) R. L. Sherwin et al. JOURNAL OF INFECTIOUS DISEASES
- A Within-Patient Analysis for Time-Varying Risk Factors of CKD Progression
- (2013) L. Li et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
- (2013) Lisa A. Jackson et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
- (2013) Lisa A. Jackson et al. VACCINE
- Risk of Community-Acquired Pneumonia in Veteran Patients to Whom Proton Pump Inhibitors Were Dispensed
- (2011) J. A. Hermos et al. CLINICAL INFECTIOUS DISEASES
- Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines
- (2011) Jan Poolman et al. Expert Review of Vaccines
- Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle‐Aged and Older Adults
- (2010) Daniel M. Musher et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical and economic burden of community-acquired pneumonia among adults in Europe
- (2010) T Welte et al. THORAX
- Etiology of Community‐Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods
- (2009) Niclas Johansson et al. CLINICAL INFECTIOUS DISEASES
- Immortal time bias in critical care research: Application of time-varying Cox regression for observational cohort studies*
- (2009) Ayumi K. Shintani et al. CRITICAL CARE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search